Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study

Kjell Larsson1 Work Environment Toxicology, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]

Christer Janson2 Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden

Björn Ställberg3 Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden

Karin Lisspers3 Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden

Petter Olsson4 Novartis AB, Täby, Sweden

Konstantinos Kostikas5 Novartis Pharma AG, Basel, Switzerland

Jean-Bernard Gruenberger5 Novartis Pharma AG, Basel, Switzerland

Florian S Gutzwiller5 Novartis Pharma AG, Basel, Switzerland

Milica Uhde6 IQVIA, Solna, Sweden

Leif Jorgensen7 IQVIA, Copenhagen, Denmark

Gunnar Johansson3 Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden

Your download is now in progress and you may close this window